Literature DB >> 11286898

Immunological and aetiological aspects of macular degeneration.

P L Penfold1, M C Madigan, M C Gillies, J M Provis.   

Abstract

Aetiological and immunological aspects of AMD, a leading cause of blindness in Western countries, have been reviewed. Developmental studies suggest that anatomical features unique to the fovea result in a critical relationship between metabolic demand and blood supply at the macula, which is maintained throughout life. Recent studies show a sufficient degree of consistency in the link between smoking and both dry and wet AMD to regard it as causative. Dry AMD is considered to be the natural endstage of the disease; epidemiological and morphological studies point to choroidal vascular atrophy as the causative event and it is suggested that signals associated with acute vascular compromise lead to the development of subretinal neovascularisation. The relationship between sub-pigment epithelial deposits, including basal laminar deposit, and the pathogenesis of AMD is examined. Much of the literature is consistent with a choroidal origin for the constituents of drusen. The blood-retinal barrier preserves the physiological environment of the neural retina and limits inflammatory responses. The factors, including cytokines, adhesion molecules and the presence of resident immunocompetent cells (microglia), which determine the immune status of the retina are considered. Historical descriptions of the involvement of inflammatory cells are provided, evidence implicating inflammation in the pathogenesis of AMD involving macrophages, giant cells and microglia has been derived from observations of human and animal subretinal neovascular lesions. The role of humoral factors such as anti-retinal autoantibodies and acute phase proteins together with clinical observations has been surveyed. Taken together these data demonstrate the involvement of both cellular and humoral immunity in the pathogenesis of AMD. It remains to be determined to what degree the influence of immunity is causative or contributory in both wet and dry AMD, however, the use of anti-inflammatory agents to ameliorate the condition further indicates the existence of an inflammatory component.

Entities:  

Mesh:

Year:  2001        PMID: 11286898     DOI: 10.1016/s1350-9462(00)00025-2

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  152 in total

1.  Intravitreal triamcinolone in recurrence of choroidal neovascularisation.

Authors:  P L Penfold
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  New insights and new approaches toward the study of age-related macular degeneration.

Authors:  Dean Bok
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-05       Impact factor: 11.205

3.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

4.  The association between statin use and age related maculopathy.

Authors:  G McGwin; C Owsley; C A Curcio; R J Crain
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 5.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

6.  Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells.

Authors:  Dongli Yang; Susan G Elner; Zong-Mei Bian; Gerd O Till; Howard R Petty; Victor M Elner
Journal:  Exp Eye Res       Date:  2007-06-27       Impact factor: 3.467

7.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

8.  Genetic loci that control the size of laser-induced choroidal neovascularization.

Authors:  Kei Nakai; Michael S Rogers; Takashi Baba; Taisaku Funakoshi; Amy E Birsner; Dema S Luyindula; Robert J D'Amato
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

Review 9.  Role of growth factors and the wound healing response in age-related macular degeneration.

Authors:  Reinier O Schlingemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 10.  'Statins in retinal disease'.

Authors:  Ahmed Al-Janabi; Sue Lightman; Oren Tomkins-Netzer
Journal:  Eye (Lond)       Date:  2018-03-20       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.